Page last updated: 2024-10-26

dipyridamole and Primary Peritonitis

dipyridamole has been researched along with Primary Peritonitis in 4 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"This study suggests that dipyridamole may have therapeutic potential in treating peritoneal fibrosis."7.71Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo. ( Fang, CC; Hsieh, BS; Hung, KY; Lee, PH; Shyu, RS; Tsai, CC; Tsai, TJ, 2001)
"This study suggests that dipyridamole may have therapeutic potential in treating peritoneal fibrosis."3.71Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo. ( Fang, CC; Hsieh, BS; Hung, KY; Lee, PH; Shyu, RS; Tsai, CC; Tsai, TJ, 2001)
"Chemical peritonitis was the dose-limiting toxicity."1.28Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole. ( Balis, FM; Cleary, SM; Goel, R; Horton, C; Howell, SB; Kirmani, S; Zimm, S, 1989)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caltik, A1
Demircin, G1
Bülbül, M1
Erdogan, O1
Akyüz, SG1
Arda, N1
Umgelter, A1
Hung, KY1
Shyu, RS1
Fang, CC1
Tsai, CC1
Lee, PH1
Tsai, TJ1
Hsieh, BS1
Goel, R1
Cleary, SM1
Horton, C1
Balis, FM1
Zimm, S1
Kirmani, S1
Howell, SB1

Reviews

1 review available for dipyridamole and Primary Peritonitis

ArticleYear
[Approach to the patient with zirrhotic ascites--no diagnosis without a tap].
    MMW Fortschritte der Medizin, 2010, Oct-21, Volume: 152, Issue:42

    Topics: Aminoglycosides; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal;

2010

Other Studies

3 other studies available for dipyridamole and Primary Peritonitis

ArticleYear
An unusual case of ANA negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and full-house nephropathy.
    Rheumatology international, 2013, Volume: 33, Issue:1

    Topics: Administration, Oral; Adolescent; Antibodies, Antinuclear; Azathioprine; Cyclophosphamide; Dipyridam

2013
Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo.
    Kidney international, 2001, Volume: 59, Issue:6

    Topics: Animals; Cell Adhesion; Cell Division; Cells, Cultured; Collagen; Cyclic AMP; Dipyridamole; Disease

2001
Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Dipyridamole; Dr

1989